泼尼松龙清除率：口腔水疱糜烂性疾病患者糖皮质激素疗效的一个可能决定因素。
Prednisolone clearance: a possible determinant for glucocorticoid efficacy in patients with oral vesiculo-erosive diseases.
作者信息
Lozada F, Frey F J, Benet L Z
出版信息
J Dent Res. 1983 May;62(5):575-7. doi: 10.1177/00220345830620051401.
PMID:6573375
Abstract
The pharmacokinetics of prednisolone were determined in 12 patients with oral vesiculo-erosive diseases. The bioavailability of prednisone in these patients exhibited a low intersubject variability, while the metabolic clearance rate of total and of unbound prednisolone varied considerably from patient to patient.
摘要
在12例口腔水疱糜烂性疾病患者中测定了泼尼松龙的药代动力学。这些患者中泼尼松的生物利用度个体间变异性较低，而总泼尼松龙和游离泼尼松龙的代谢清除率在患者之间差异很大。
相似文献
1
Prednisolone clearance: a possible determinant for glucocorticoid efficacy in patients with oral vesiculo-erosive diseases.
J Dent Res. 1983 May;62(5):575-7. doi: 10.1177/00220345830620051401.
2
Bioavailability and reversible metabolism of prednisone and prednisolone in man.
Biopharm Drug Dispos. 1994 Mar;15(2):163-72. doi: 10.1002/bdd.2510150208.
3
Clinical pharmacokinetics of prednisone and prednisolone.
Clin Pharmacokinet. 1979 Mar-Apr;4(2):111-28. doi: 10.2165/00003088-197904020-00004.
4
A single dose of azathioprine does not affect the pharmacokinetics of prednisolone following oral prednisone.
Eur J Clin Pharmacol. 1981 Feb;19(3):209-12. doi: 10.1007/BF00561951.
5
Prednisone and prednisolone bioavailability in renal transplant patients.
Kidney Int. 1982 Apr;21(4):621-6. doi: 10.1038/ki.1982.69.
6
Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis.
Gut. 1980 Jan;21(1):52-6. doi: 10.1136/gut.21.1.52.
7
Monitoring prednisone and prednisolone.
Ther Drug Monit. 1980;2(2):169-76. doi: 10.1097/00007691-198004000-00011.
8
Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone.
Eur J Clin Pharmacol. 1984;26(4):505-11. doi: 10.1007/BF00542149.
9
Altered metabolism and decreased efficacy of prednisolone and prednisone in patients with hyperthyroidism.
Clin Pharmacol Ther. 1988 Nov;44(5):510-21. doi: 10.1038/clpt.1988.188.
10
Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
Gastroenterology. 1977 May;72(5 Pt 1):910-3.
引用本文的文献
1
Efficacy of Prednisolone Mouthwash in Management of Grade III Oral Submucous Fibrosis: A Newer Drug Regimen.
J Maxillofac Oral Surg. 2020 Dec;19(4):532-538. doi: 10.1007/s12663-019-01248-3. Epub 2019 May 28.
Zotero 插件